Open for Enrollment

Pediatrics

SP847
A multicenter, open-label study to investigate the safety, tolerability, and pharmacokinetics of lacosamide (LCM) oral solution (Syrup) as adjunctive therapy in children with partial-onset seizures.

SP848
An open-label extension study to determine safety, tolerability, and efficacy of long-term oral lacosamide (LCM) as adjunctive therapy in children with partial-onset seizures

A Multi-Center, Open-Label Study to Investigate the Pharmacokinetics of Commercial Lacosamide Oral Formulation as Therapy in children )age 1month to 17 years) with Epilepsy